Capstone Financial Advisors, Inc. Bristol Myers Squibb CO Transaction History

Capstone Financial Advisors, Inc.

$1.62 Billion
Q4 2024

A detailed history of Capstone Financial Advisors, Inc. transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Capstone Financial Advisors, Inc. holds 17,849 shares of BMY stock, worth $1.13 Million. This represents 0.06% of its overall portfolio holdings.

Number of Shares

17,849

Previous 22,434 20.44%

Holding current value

$1.13 Million

Previous $1.16 Million 13.02%

% of portfolio

0.06%

Previous 0.07%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	SELL	$51.92 - $59.94 $238,053 - $274,824	-4,585 Reduced 20.44%	17,849 $1.01 Million
Q3 2024 Nov 14, 2024	SELL	$39.66 - $51.75 $912 - $1,190	-23 Reduced 0.1%	22,434 $1.16 Million
Q2 2024 Aug 13, 2024	BUY	$40.25 - $52.99 $12,839 - $16,903	319 Added 1.44%	22,457 $932,000
Q1 2024 May 14, 2024	BUY	$47.98 - $54.4 $380,481 - $431,392	7,930 Added 55.81%	22,138 $1.2 Million
Q4 2023 Feb 13, 2024	SELL	$48.48 - $57.85 $2,714 - $3,239	-56 Reduced 0.39%	14,208 $729,000
Q3 2023 Nov 13, 2023	SELL	$57.89 - $64.73 $23,213 - $25,956	-401 Reduced 2.73%	14,264 $827,000
Q2 2023 Aug 14, 2023	BUY	$63.71 - $70.74 $61,416 - $68,193	964 Added 7.04%	14,665 $937,000
Q1 2023 May 12, 2023	BUY	$65.71 - $74.53 $14,981 - $16,992	228 Added 1.69%	13,701 $949,000
Q4 2022 Feb 15, 2023	SELL	$68.48 - $81.09 $76,149 - $90,172	-1,112 Reduced 7.62%	13,473 $969,000
Q3 2022 Nov 14, 2022	SELL	$0.13 - $76.84 $16 - $9,835	-128 Reduced 0.87%	14,585 $1.04 Million
Q2 2022 Sep 02, 2022	SELL	$72.62 - $79.98 $42,264 - $46,548	-582 Reduced 3.81%	14,713 $1.13 Million
Q1 2022 May 13, 2022	BUY	$61.48 - $73.72 $458,333 - $549,582	7,455 Added 95.09%	15,295 $1.12 Million
Q4 2021 Feb 11, 2022	BUY	$53.63 - $62.52 $35,342 - $41,200	659 Added 9.18%	7,840 $489,000
Q3 2021 Nov 15, 2021	BUY	$59.17 - $69.31 $5,029 - $5,891	85 Added 1.2%	7,181 $425,000
Q2 2021 Aug 16, 2021	BUY	$61.91 - $67.42 $2,909 - $3,168	47 Added 0.67%	7,096 $474,000
Q1 2021 May 13, 2021	BUY	$59.34 - $66.74 $109,838 - $123,535	1,851 Added 35.61%	7,049 $445,000
Q4 2020 Feb 16, 2021	BUY	$57.74 - $65.43 $77,833 - $88,199	1,348 Added 35.01%	5,198 $322,000
Q4 2019 Feb 14, 2020	BUY	$49.21 - $64.19 $189,458 - $247,131	3,850 New	3,850 $247,000

Others Institutions Holding BMY

# of Institutions

2,761

Shares Held

1.57B

Call Options Held

28M

Put Options Held

28.7M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $134B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Capstone Financial Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Capstone Financial Advisors, Inc. with notifications on news.

Account

Capstone Financial Advisors, Inc. Bristol Myers Squibb CO Transaction History